AKTS · Aktis Oncology, Inc. · Proposed Sales
$15.73
-1.03 (-6.15%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$874.89M
Shares
55.62M
Volume · Oct 23
241.76K
Avg daily vol (3M)
364.06K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-23 | Akos Czibere | Officer | 25,000 | 2026-09-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-20 | KEN HERRMANN | Director | 4,856 | 2026-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-17 | KEN HERRMANN | Director | 3,065 | 2026-07-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-08 | AKOS CZIBERE | Officer | 50,000 | 2026-07-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-08 | SHULAMIT RON-BIGGER | Officer | 50,000 | 2026-07-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings
Key facts
CIK
2035832
CUSIP
01021M104
13F (30d)
10 filings
10 filers
Visit website
Investor relations